Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I—Initial Work-up and Medical Management. Erratum
is correction of
Volume 206, Issue 4, Page 806: The second sentence on page 813 should read: “The reduction in risk, defined as an increase above baseline of at least 4 points in the IPSS, AUR, urinary incontinence, renal insufficiency, or recurrent UTI, was significantly greater with combination therapy than that associated with doxazosin or finasteride alone.” The online and PDF versions of the article have been corrected.